Bastiaan Evers
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target.
Journal: Nature
Published: September 03, 2024
Double-strand break toxicity is chromatin context independent.
Journal: Nucleic acids research
Published: March 28, 2022
DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II.
Journal: Nature communications
Published: December 04, 2020
Elongation factor ELOF1 drives transcription-coupled repair and prevents genome instability.
Journal: Nature cell biology
Published: June 24, 2020
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
Journal: Nature
Published: October 18, 2018
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
Journal: Journal of hepatology
Published: February 15, 2018
The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.
Journal: Cell reports
Published: January 31, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Journal: Oncogene
Published: November 27, 2017
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma.
Journal: Cell research
Published: October 09, 2017
Last Updated: 09/26/2026